BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 26152360)

  • 1. A rare KMT2A::CBL transcript in an acute monoblastic leukemia patient with an unfavorable outcome.
    Yu J; Song F; Zhang M; Xiao P; Feng J; Hong R; Hu Y; Huang H; Wei G
    Mol Biol Rep; 2024 Apr; 51(1):561. PubMed ID: 38643442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoform alterations in the ubiquitination machinery impacting gastrointestinal malignancies.
    Kasturirangan S; Nancarrow DJ; Shah A; Lagisetty KH; Lawrence TS; Beer DG; Ray D
    Cell Death Dis; 2024 Mar; 15(3):194. PubMed ID: 38453895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide profiling of alternative splicing in glioblastoma and their clinical value.
    Li Y; Guo D
    BMC Cancer; 2021 Aug; 21(1):958. PubMed ID: 34445990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Ubiquitin Proteasome System in Glioma: Analysis Emphasizing the Main Molecular Players and Therapeutic Strategies Identified in Glioblastoma Multiforme.
    Maksoud S
    Mol Neurobiol; 2021 Jul; 58(7):3252-3269. PubMed ID: 33665742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant.
    Ji J; Navid F; Hiemenz MC; Kaneko M; Zhou S; Saitta SC; Biegel JA
    Cancer Genet; 2019 Feb; 231-232():62-66. PubMed ID: 30803559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of EGFR Endocytosis by CBL During Mitosis.
    Wee P; Wang Z
    Cells; 2018 Dec; 7(12):. PubMed ID: 30544639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA processing as an alternative route to attack glioblastoma.
    Marcelino Meliso F; Hubert CG; Favoretto Galante PA; Penalva LO
    Hum Genet; 2017 Sep; 136(9):1129-1141. PubMed ID: 28608251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of c-Cbl in myeloid malignancies.
    Katzav S; Schmitz ML
    Oncotarget; 2015 May; 6(13):10689-96. PubMed ID: 26028666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.
    Ogawa S; Sanada M; Shih LY; Suzuki T; Otsu M; Nakauchi H; Koeffler HP
    Cell Cycle; 2010 Mar; 9(6):1051-6. PubMed ID: 20237427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleterious c-Cbl Exon Skipping Contributes to Human Glioma.
    Seong MW; Ka SH; Park JH; Park JH; Yoo HM; Yang SW; Park JM; Park D; Lee ST; Seol JH; Chung CH
    Neoplasia; 2015 Jun; 17(6):518-24. PubMed ID: 26152360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Cbl regulates αPix-mediated cell migration and invasion.
    Seong MW; Park JH; Yoo HM; Yang SW; Oh KH; Ka SH; Park DE; Lee ST; Chung CH
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):153-8. PubMed ID: 25450678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B.
    Kwak SY; Kim BY; Ahn HJ; Yoo JO; Kim J; Bae IH; Han YH
    FEBS J; 2015 Apr; 282(8):1512-25. PubMed ID: 25691332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
    Makishima H; Sugimoto Y; Szpurka H; Clemente MJ; Ng KP; Muramatsu H; O'Keefe C; Saunthararajah Y; Maciejewski JP
    Leukemia; 2012 Jul; 26(7):1547-54. PubMed ID: 22246246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
    Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
    Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
    Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
    J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.